MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells

Journal of Experimental Medicine

Volumn 209, Issue 9, 2012, Pages 1671-1687

  Ochi, Atsuo ^a   Nguyen, Andrew H ^a   Bedrosian, Andrea S ^a   Mushlin, Harry M ^a   Zarbakhsh, Saman ^a   Barilla, Rocky ^a   Zambirinis, Constantinos P ^a   Fallon, Nina C ^a   Rehman, Adeel ^a   Pylayeva Gupta, Yuliya ^a   Badar, Sana ^a   Hajdu, Cristina H ^a   Frey, Alan B ^a   Bar Sagi, Dafna ^a   Miller, George ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMYLASE; BETA ACTIN; CALGRANULIN B; CD11B ANTIGEN; CD209 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOKERATIN 19; DESMIN; FLT3 LIGAND; GLYCOPROTEIN P 15095; HIGH MOBILITY GROUP B1 PROTEIN; INSULIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 10; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; T6 ANTIGEN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; HUMAN; HUMAN TISSUE; INFLAMMATION; INFLAMMATORY CELL; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PANCREATIC CARCINOGENESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TH2 CELL;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADENOCARCINOMA; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; MALE; MICE; MICE, MUTANT STRAINS; MYELOID DIFFERENTIATION FACTOR 88; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; TH2 CELLS; TOLL-LIKE RECEPTOR 4;

EID: 84866372497     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111706     Document Type: Article

References (56)

1. Agbunag, C., K.E. Lee, S. Buontempo, and D. Bar-Sagi. 2006. Pancreatic duct epithelial cell isolation and cultivation in two-dimensional and three- dimensional culture systems. Methods Enzymol. 407:703-710. http://dx.doi.org/10.1016/S0076-6879(05)07055-2
2. Ahn, J., C.Y. Chen, and R.B. Hayes. 2012. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 23:399-404. http:// dx.doi.org/10.1007/s10552-011-9892-7
3. Ammann, R.W., A. Akovbiantz, F. Largiader, and G. Schueler. 1984. Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology. 86:820-828.
4. Bantsimba-Malanda, C., J. Marchal-Sommé, D. Goven, O. Freynet, L. Michel, B. Crestani, and P. Soler. 2010. A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice? Am. J. Respir. Crit. Care Med. 182:385-395. http://dx.doi.org/10.1164/rccm.200907-1164OC
5. Barrat, F.J., and R.L. Coffman. 2008. Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol. Rev. 223:271-283. http://dx.doi.org/10.1111/j.1600-065X.2008.00630.x
6. Bedrosian, A.S., A.H. Nguyen, M. Hackman, M.K. Connolly, A. Malhotra, J. Ibrahim, N.E. Cieza-Rubio, J.R. Henning, R. Barilla, A. Rehman, et al. 2011. Dendritic cells promote pancreatic viability in mice with acute pancreatitis. Gastroenterology. 141:1915-1926: e1-e14. http://dx.doi.org/ 10.1053/j.gastro.2011.07.033
7. Braganza, J.M., S.H. Lee, R.F. McCloy, and M.J. McMahon. 2011. Chronic pancreatitis. Lancet. 377:1184-1197. http://dx.doi.org/10.1016/S0140-6736(10)61852-1
8. Carrière, C., A.L. Young, J.R. Gunn, D.S. Longnecker, and M. Korc. 2009. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 382: 561-565. http://dx.doi.org/10.1016/j.bbrc.2009.03.068
9. Carrière, C., A.J. Gore, A.M. Norris, J.R. Gunn, A.L. Young, D.S. Longnecker, and M. Korc. 2011. Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions. Gastroenterology. 141:1091-1101. http://dx.doi.org/10.1053/j.gastro.2011 .05.041
10. Chen, L., L. Lei, X. Chang, Z. Li, C. Lu, X. Zhang, Y. Wu, I.T. Yeh, and G. Zhong. 2010. Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J. Immunol. 184:2602-2610. http://dx.doi.org/ 10.4049/jimmunol.0901593
11. Colotta, F., P. Allavena, A. Sica, C. Garlanda, and A. Mantovani. 2009. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 30:1073-1081. http://dx.doi.org/10.1093/carcin/ bgp127
12. Connolly, M.K., A.S. Bedrosian, J. Mallen-St Clair, A.P. Mitchell, J. Ibrahim, A. Stroud, H.L. Pachter, D. Bar-Sagi, A.B. Frey, and G. Miller. 2009. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 119:3213-3225.
13. Connolly, M.K., J. Mallen-St Clair, A.S. Bedrosian, A. Malhotra, V. Vera, J. Ibrahim, J. Henning, H.L. Pachter, D. Bar-Sagi, A.B. Frey, and G. Miller. 2010. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J. Leukoc. Biol. 87:713-725. http://dx.doi.org/10.1189/jlb.0909607
14. Connolly, M.K., D. Ayo, A. Malhotra, M. Hackman, A.S. Bedrosian, J. Ibrahim, N.E. Cieza-Rubio, A.H. Nguyen, J.R. Henning, M. Dorvil-Castro, et al. 2011. Dendritic cell depletion exacerbates acetaminophen hepatotoxicity. Hepatology. 54:959-968. http://dx.doi.org/10.1002/hep.24429
15. Coste, I., K. Le Corf, A. Kfoury, I. Hmitou, S. Druillennec, P. Hainaut, A. Eychene, S. Lebecque, and T. Renno. 2010. Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J. Clin. Invest. 120:3663-3667. http://dx.doi.org/10.1172/JCI42771
16. Creusot, R.J., S.S. Yaghoubi, P. Chang, J. Chia, C.H. Contag, S.S. Gambhir, and C.G. Fathman. 2009. Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood. 113:6638-6647. http://dx.doi .org/10.1182/blood-2009-02-204321
17. Dapito, D.H., A. Mencin, G.Y. Gwak, J.P. Pradere, M.K. Jang, I. Mederacke, J.M. Caviglia, H. Khiabanian, A. Adeyemi, R. Bataller, et al. 2012. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 21:504-516. http://dx.doi.org/10.1016/j.ccr.2012.02.007
18. De Monte, L., M. Reni, E. Tassi, D. Clavenna, I. Papa, H. Recalde, M. Braga, V. Di Carlo, C. Doglioni, and M.P. Protti. 2011. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J. Exp. Med. 208:469-478. http://dx.doi.org/10.1084/ jem.20101876
19. Demols, A., O. Le Moine, F. Desalle, E. Quertinmont, J.L. Van Laethem, and J. Devière. 2000. CD4(+ )T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology. 118:582-590. http:// dx.doi.org/10.1016/S0016-5085(00)70265-4
20. Ding, S.Q., Y. Li, Z.G. Zhou, C. Wang, L. Zhan, and B. Zhou. 2010. Toll-like receptor 4-mediated apoptosis of pancreatic cells in cerulein-induced acute pancreatitis in mice. HBPD INT. 9:645-650.
21. Gasse, P., C. Mary, I. Guenon, N. Noulin, S. Charron, S. Schnyder-Candrian, B. Schnyder, S. Akira, V.F. Quesniaux, V. Lagente, et al. 2007. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J. Clin. Invest. 117:3786-3799.
22. Greer, J.B., and D.C. Whitcomb. 2009. Inflammation and pancreatic cancer: an evidence-based review. Curr. Opin. Pharmacol. 9:411-418. http://dx.doi .org/10.1016/j.coph.2009.06.011
23. Guo, J., J. Loke, F. Zheng, F. Hong, S. Yea, M. Fukata, M. Tarocchi, O.T. Abar, H. Huang, J.J. Sninsky, and S.L. Friedman. 2009. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology. 49:960-968. http:// dx.doi.org/10.1002/hep.22697
24. Hauben, E., S. Gregori, E. Draghici, B. Migliavacca, S. Olivieri, M. Woisetschläger, and M.G. Roncarolo. 2008. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood. 112: 1214-1222. http://dx.doi.org/10.1182/blood-2007-08-109843
25. Hellerbrand, S.C., S.C. Wang, H. Tsukamoto, D.A. Brenner, and R.A. Rippe. 1996. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology. 24:670-676. http://dx.doi.org/10.1002/ hep.510240333
26. Hingorani, S.R., E.F. Petricoin, A. Maitra, V. Rajapakse, C. King, M.A. Jacobetz, S. Ross, T.P. Conrads, T.D. Veenstra, B.A. Hitt, et al. 2003. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 4: 437-450. http://dx.doi.org/10.1016/S1535-6108(03)00309-X
27. Hou, B., B. Reizis, and A.L. DeFranco. 2008. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and-extrinsic mechanisms. Immunity. 29: 272-282. http://dx.doi.org/10.1016/j.immuni .2008.05.016
28. Hruban, R.H., K. Takaori, D.S. Klimstra, N.V. Adsay, J. Albores-Saavedra, A.V. Biankin, S.A. Biankin, C. Compton, N. Fukushima, T. Furukawa, et al. 2004. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am. J. Surg. Pathol. 28: 977-987. http://dx.doi.org/10.1097/01.pas .0000126675.59108.80
29. Ito, T., Y.H. Wang, O. Duramad, T. Hori, G.J. Delespesse, N. Watanabe, F.X. Qin, Z. Yao, W. Cao, and Y.J. Liu. 2005. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202: 1213-1223. http://dx.doi.org/10.1084/jem.20051135
30. Jura, N., H. Archer, and D. Bar-Sagi. 2005. Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between. Cell Res. 15: 72-77. http://dx.doi.org/10.1038/sj.cr.7290269
31. Kaisho, T., K. Hoshino, T. Iwabe, O. Takeuchi, T. Yasui, and S. Akira. 2002. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int. Immunol. 14: 695-700. http://dx.doi.org/ 10.1093/intimm/dxf039
32. Kapsenberg, M.L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993. http://dx.doi.org/10.1038/nri1246
33. Lankisch, P.G., A. Löhr-Happe, J. Otto, and W. Creutzfeldt. 1993. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion. 54: 148-155. http:// dx.doi.org/10.1159/000201029
34. Liu, T., T.L. Li, F. Zhao, C. Xie, A.M. Liu, X. Chen, C. Song, L. Cheng, and P.C. Yang. 2011. Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis. Am. J. Med. Sci. 341: 40-47. http://dx.doi.org/ 10.1097/MAJ.0b013e3181f20489
35. Mantovani, A., C. Garlanda, and P. Allavena. 2010. Molecular pathways and targets in cancer-related inflammation. Ann. Med. 42: 161-170. http:// dx.doi.org/10.3109/07853890903405753
36. Maraskovsky, E., K. Brasel, M. Teepe, E.R. Roux, S.D. Lyman, K. Shortman, and H.J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962. http://dx.doi.org/10.1084/jem.184.5.1953
37. Masamune, A., T. Watanabe, K. Kikuta, and T. Shimosegawa. 2009. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol. Hepatol. 7:S48-S54. http://dx.doi.org/10.1016/j.cgh.2009.07.038
38. Miller, G., S. Lahrs, V.G. Pillarisetty, A.B. Shah, and R.P. DeMatteo. 2002. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. Cancer Res. 62:5260-5266.
39. Miller, G., S. Lahrs, and R.P. Dematteo. 2003. Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity. FASEB J. 17:728-730.
40. Nevala, W.K., C.M. Vachon, A.A. Leontovich, C.G. Scott, M.A. Thompson, and S.N. Markovic; Melanoma Study Group of the Mayo Clinic Cancer Center. 2009. Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma. Clin. Cancer Res. 15: 1931-1939. http://dx.doi.org/10.1158/1078-0432.CCR-08-1980
41. O'Neill, D.W., S. Adams, and N. Bhardwaj. 2004. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood. 104: 2235-2246. http://dx.doi.org/10.1182/blood-2003-12-4392
42. Oiva, J., H. Mustonen, M.L. Kylänpää, L. Kyhälä, K. Kuuliala, S. Siitonen, E. Kemppainen, P. Puolakkainen, and H. Repo. 2010. Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling: controlled laboratory study. Crit. Care. 14:R207. http://dx.doi.org/ 10.1186/cc9329
43. Omary, M.B., A. Lugea, A.W. Lowe, and S.J. Pandol. 2007. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J. Clin. Invest. 117: 50-59. http://dx.doi.org/10.1172/JCI30082
44. Osawa, E., A. Nakajima, T. Fujisawa, Y.I. Kawamura, N. Toyama-Sorimachi, H. Nakagama, and T. Dohi. 2006. Predominant T helper type 2-inflammatory responses promote murine colon cancers. Int. J. Cancer. 118:2232-2236. http://dx.doi.org/10.1002/ijc.21639
45. Palucka, K., H. Ueno, J. Fay, and J. Banchereau. 2009. Harnessing dendritic cells to generate cancer vaccines. Ann. N. Y. Acad. Sci. 1174: 88-98. http://dx.doi.org/10.1111/j.1749-6632.2009.05000.x
46. Petersen, T.R., N. Dickgreber, and I.F. Hermans. 2010. Tumor antigen presentation by dendritic cells. Crit. Rev. Immunol. 30: 345-386. http://dx.doi .org/10.1615/CritRevImmunol.v30.i4.30
47. Pylayeva-Gupta, Y., K.E. Lee, C.H. Hajdu, G. Miller, and D. Bar-Sagi. 2012. Oncogenic Kras-Induced GM-CSF Production Promotes the Development of Pancreatic Neoplasia. Cancer Cell. 21: 836-847. http://dx.doi.org/ 10.1016/j.ccr.2012.04.024
48. Rakoff-Nahoum, S., and R. Medzhitov. 2007. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science. 317: 124-127. http://dx.doi.org/10.1126/science.1140488
49. Ricci, F., S.E. Kern, R.H. Hruban, and C.A. Iacobuzio-Donahue. 2005. Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype. Cancer Biol. Ther. 4: 302-307. http://dx.doi.org/10.4161/cbt.4.3.1501
50. Robson, N.C., S. Hoves, E. Maraskovsky, and M. Schnurr. 2010. Presentation of tumour antigens by dendritic cells and challenges faced. Curr. Opin. Immunol. 22: 137-144. http://dx.doi.org/10.1016/j.coi.2010.01.002
51. Sharif, R., R. Dawra, K. Wasiluk, P. Phillips, V. Dudeja, E. Kurt-Jones, R. Finberg, and A. Saluja. 2009. Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut. 58: 813-819. http://dx.doi.org/10.1136/gut.2008.170423
52. Swann, J.B., M.D. Vesely, A. Silva, J. Sharkey, S. Akira, R.D. Schreiber, and M.J. Smyth. 2008. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl. Acad. Sci. USA. 105: 652-656. http://dx.doi.org/10.1073/pnas.0708594105
53. Vaquero, E., I. Gukovsky, V. Zaninovic, A.S. Gukovskaya, and S.J. Pandol. 2001. Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G1197-G1208.
54. Vincent, A., J. Herman, R. Schulick, R.H. Hruban, and M. Goggins. 2011. Pancreatic cancer. Lancet. 378: 607-620. http://dx.doi.org/10.1016/ S0140-6736(10)62307-0
55. Wang, Z., D. Kong, S. Banerjee, Y. Li, N.V. Adsay, J. Abbruzzese, and F.H. Sarkar. 2007. Down-regulation of platelet-derived growth factor-D in-hibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer Res. 67: 11377-11385. http:// dx.doi.org/10.1158/0008-5472.CAN-07-2803
56. Zhou, X.Y., Z.G. Zhou, J.L. Ding, L. Wang, R. Wang, B. Zhou, J. Gu, X.F. Sun, and Y. Li. 2010. TRAF6 as the key adaptor of TLR4 signaling pathway is involved in acute pancreatitis. Pancreas. 39: 359-366. http://dx.doi.org/10.1097/MPA.0b013e3181bb9073